{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:41:19Z","timestamp":1770990079690,"version":"3.50.1"},"reference-count":46,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1586\/ehm.13.15","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T04:49:36Z","timestamp":1371703776000},"page":"239-246","source":"Crossref","is-referenced-by-count":9,"title":["Iron (III) isomaltoside 1000"],"prefix":"10.1586","volume":"6","author":[{"given":"Thomas AR","family":"Mace","sequence":"first","affiliation":[{"name":"Hull York Medical School, Hertford Building, University of Hull, Hull, HU6 7RX, UK."},{"name":"Hull and East Yorkshire NHS Trust, Renal Secretaries, Alderson House, Hull Royal Infirmary, Anlaby Road, Hull, HU3 2JZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Syed","sequence":"additional","affiliation":[{"name":"Hull and East Yorkshire NHS Trust, Renal Secretaries, Alderson House, Hull Royal Infirmary, Anlaby Road, Hull, HU3 2JZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Hertford Building, University of Hull, Hull, HU6 7RX, UK."},{"name":"Hull and East Yorkshire NHS Trust, Renal Secretaries, Alderson House, Hull Royal Infirmary, Anlaby Road, Hull, HU3 2JZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980008002401"},{"key":"e_1_3_2_5_1","volume-title":"Iron Deficiency Anaemia: Assessment, Prevention and Control. A Guide for Programme Managers","author":"WHO, UNICEF, UNU","year":"2001","unstructured":"WHO, UNICEF, UNU. Iron Deficiency Anaemia: Assessment, Prevention and Control. A Guide for Programme Managers. World Health Organization, Geneva, Switzerland (2001)."},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0884533608314536"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.2741\/3794"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.01.107"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.37"},{"key":"e_1_3_2_10_1","volume-title":"Anaemia Management in Chronic Kidney Disease: National Clinical Guideline for Management in Adults and Children","author":"National Collaborating Centre for Chronic Conditions","year":"2006","unstructured":"National Collaborating Centre for Chronic Conditions. In: Anaemia Management in Chronic Kidney Disease: National Clinical Guideline for Management in Adults and Children. Royal College of Physicians, London, UK (2006)."},{"key":"e_1_3_2_11_1","first-page":"161","volume":"19","author":"Gotloib","year":"2006","unstructured":"Gotloib L, Silverberg D, Fudin R, Shostak A. Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J. Nephrol. 19(2), 161\u2013167 (2006).","journal-title":"J. Nephrol."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1109"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907845"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065485"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041809"},{"key":"e_1_3_2_16_1","first-page":"12","volume":"23","author":"Chaplin","year":"2012","unstructured":"Chaplin S, Bhandari S. Oral iron: properties and current place in the treatment of anaemia. Prescriber 23, 12\u201318 (2012).","journal-title":"Prescriber"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-007-0388-3"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/08860229709037217"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69061.x"},{"key":"e_1_3_2_20_1","first-page":"CD007857","volume":"1","author":"Albaramki","year":"2012","unstructured":"Albaramki J, Hodson EM, Craig JC, Webster AC. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst. Rev. 1, CD007857 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_21_1","unstructured":"Reinso\u00ae (ferumoxytol) prescribing information. Takeda Pharmaceuticals Osaka Japan (2012)."},{"key":"e_1_3_2_22_1","first-page":"S93","volume":"15","author":"Danielson","year":"2004","unstructured":"Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J. Am. Soc. Nephrol. 15(Suppl. 2), S93\u2013S98 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.5301\/JN.2011.6248"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1778-428X.2010.01145.x"},{"key":"e_1_3_2_25_1","first-page":"301","volume":"100","author":"Ganzoni","year":"1970","unstructured":"Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz. Med. Wochenschr. 100(7), 301\u2013303 (1970).","journal-title":"Schweiz. Med. Wochenschr."},{"key":"e_1_3_2_26_1","unstructured":"Monofer\u00ae (iron isomaltoside 1000) prescribing information. Pharmacosmos Holbaek Denmark (2012)."},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2011.03.016"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S30015"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00742.x"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi253"},{"key":"e_1_3_2_31_1","first-page":"13","volume":"26","author":"Kalra","year":"2012","unstructured":"Kalra PA, Bock K, Meldal M. Iron isomaltoside 1000: a new high dose option for parenteral iron therapy. Port. J Nephrol. Hypertens. 26(1), 13\u201324 (2012).","journal-title":"Port. J Nephrol. Hypertens."},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1988.tb05741.x"},{"key":"e_1_3_2_33_1","unstructured":"Kalra PA Bhandari S Thomsen LL. One visit iron repletion with iron isomaltoside 1000 (Monofer\u00ae) in CKD and CHF patients. Presented at: ASN 43rd Annual Meeting. Denver CO USA 16\u201321 November 2010."},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00471.x"},{"key":"e_1_3_2_35_1","first-page":"S107","volume":"15","author":"Van Wyck","year":"2004","unstructured":"Van Wyck DB. Labile iron: manifestations and clinical implications. J. Am. Soc. Nephrol. 15(Suppl. 2), S107\u2013S111 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152812798889358"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01410406"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00716.x"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00648.x"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.119"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2007.00932.x"},{"key":"e_1_3_2_42_1","unstructured":"Ferinject\u00ae (ferric carboxymaltose) prescribing information. Vifor Pharmaceuticals Glattbrugg Switzerland (2011)."},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22153"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1159\/000334877"},{"key":"e_1_3_2_45_1","unstructured":"Venofer\u00ae (iron sucrose) prescribing information. Vifor Pharmaceuticals Glattsbrugg Switzerland (2011)."},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S25882"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-245977"},{"key":"e_1_3_3_2_1","unstructured":"List of Monofer clinical trials. http:\/\/clinicaltrials.gov\/ct2\/results?term=monofer"},{"key":"e_1_3_3_3_1","unstructured":"ClinicalTrials.gov. http:\/\/clinicaltrials.gov"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/ehm.13.15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:45:38Z","timestamp":1770374738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/ehm.13.15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1586\/ehm.13.15"],"URL":"https:\/\/doi.org\/10.1586\/ehm.13.15","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}